It has been suggested that in presumed cancer-associated retinopathy, AAbs are likely made against tumor antigens like recoverin that cross-react with retina, and such antibodies might be responsible for eliminating tumors and at the same time targeting the retinal autoantigens, in effect causing photoreceptor degeneration [16,17,18,19]. Here, RCVRN is linked to retinal disorder.